Mounjaro 'golden dose' revealed to stop 'food noise'
Patient dosage, starting body mass index (BMI) and percentage of body weight lost were reviewed, to provide people exploring treatment a realistic snapshot of what to expect and show what real success looks like.
Mounjaro users report surprising side effect - pharmacists share their tips https://t.co/9tXoCc5gCk https://t.co/KGLZUpUbcL — Telegraph & Argus (@Bradford_TandA) August 5, 2025
Leading online pharmaceutical company Oxford Online Pharmacy has conducted a study of 100 anonymised patients prescribed once-weekly Mounjaro (tirzepatide) injections.
The data aims to counteract unhealthy beliefs that hunger equals failure, which may lead to unnecessary concerns and calls for increased doses. The analysis revealed that patients in the analysis lost up to 39kg, with consistent results across a range of doses.
Kiran Jones, Clinical Pharmacist at Oxford Online Pharmacy, says: 'This study reinforces that healthy, sustainable weight loss is possible without excessive pressure or maximal dosing.
'People think these medicines switch off hunger completely, but that's not how they work. Being able to eat is normal. Success looks different for everyone, and often, the biggest wins are quiet ones: more energy, less breathlessness, and better sleep.
'Becoming healthier without extreme diets or private clinics is a powerful example of what good, regulated care can achieve. Patients need safety, not pressure.'
All patients started on the recommended dose of 2.5mg, which gradually increased depending on individual response (up to 12.5mg), with 86% maintaining a moderate dose of 10mg or lower. The most common dose for over half of the patients was 5mg.
It varies for everyone, but I did 6 months of Mounjaro and "I feel absolutely starving when I don't eat enough" was 100% gone. However, dosing is poorly managed. They wanted to increase all the time and that made me sick, so I stayed on the lowest dose and it worked great. — Peter Cooper (@cooperx86) August 5, 2025
Weight loss generally increased with dose, but the data shows this does not follow a strictly linear pattern. Patients on 7.5mg showed the highest average weight loss overall, showing smaller doses can be effective, and making this the 'golden dose' for many people.
Similarly, higher BMI correlated with greater weight loss, but not in all patients.
The study also highlights the importance of celebrating non-weight loss wins, discussing how the right dose helps users strike a balance between appetite control, tolerability and overall wellbeing.
However, the experts say that they should not switch off hunger entirely - it just helps regulate appetite and increase feelings of satisfaction. Being able to enjoy food can be a sign that the medicine is working appropriately.
Meanwhile, before experiencing weight loss, patients reported improvements, including better sleep, more stable energy and mood, reduced cravings, and increased motivation to move.
What is 'food noise'?
'Food noise' is thinking about food even when you aren't physically in need of food. Experts say it is a psychologically driven process, unlike real hunger, which comes from your body needing nutrients and fuel.
GP registrar Dr Jack Mosley – whose dad was BBC presenter Dr Michael Mosley - has written a book titled Food Noise.
Recommended reading:
"There's multiple reasons we eat," he says. "One of the big drivers is simply appetite, and that's centrally controlled in our brain and through our guts.
"But our cravings – that internal food monologue, which I refer to as the 'food noise' – that can be turned up if you are hungry, but plenty of people, eat even when they're not hungry.
"Many of us can relate to it, when we're stressed, we're not typically eating nutritious foods. We want that easy, accessible junk food. So we want the sugary, salty snacks. We want that sugar high. The weight-loss drugs can reduce our appetite and our cravings, but they're not necessarily going to address things like our emotional hunger."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
44 minutes ago
- BBC News
'NHS cut funding after Gran didn't die on time'
A woman has accused the NHS of withdrawing funding for her 98-year-old grandmother's care because "she didn't die on time".Pearl, from Bradford, has advanced dementia and was fast-tracked onto NHS Continuing Healthcare (CHC) in 2023 to support her at home after a hospital granddaughter, Kirstie Lumley, said she was now being left to "die without dignity" after funding was stopped when a review found her needs were no longer primarily West Yorkshire Integrated Care Board (WYICB) acknowledged its funding decisions could cause "disappointment and distress" but added they were "based on an individual's assessed needs, not their diagnosis or financial situation". In June 2023, Pearl's family were told she required end-of-life care after being discharged from hospital following a urinary tract the time she was deemed eligible for fast track CHC, which allows quick access to NHS funding for patients who have a "rapidly deteriorating condition" and "may be entering a terminal phase".Last month, following a review of her case, the family was told that funding would cease on 1 August Lumley, from Malton, North Yorkshire, said the decision felt "unfair" because her grandmother's condition was "certainly no better" than when she was originally funded."She was expected to pass away in 2023 when she was discharged from hospital with an estimated prognosis of six weeks," she said."Because she's outlived that by a huge period of time, it's like she hasn't ticked the box and died on time." Pearl had been receiving 86 hours of NHS-funded care each week, which her family had been topping up with an extra 14 hours of care paid for Council, which has now taken over responsibility, has said she will receive just over 19 hours a week, which the family will have to pay towards, meaning they can no longer afford extra private also means Pearl will no longer have a carer to sit with her overnight and will instead have one 30-minute visit for toilet the changes, she has already fallen out of bed once in the middle of the night, requiring paramedics to be called."She's scared, she's upset, she's confused," Ms Lumley said."Knowing that she might be in that state and be upset and shouting out for help for another five or six hours until a carer arrives, who will only be with her for half an hour, it's just heartbreaking," she said. NHS data shows that at the end of March 2025 more than 51,000 patients in England were eligible for CHC, with almost a third qualifying via the fast track guidance states there may be situations where it is "appropriate to review eligibility" for fast track CHC but goes on to say that where a patient is "expected to die in the very near future" the ICB should continue to take responsibility for the care UK has launched a Fix the Funding campaign, which is calling on the government to urgently review the assessment process for CHC, which it believes is flawed and does not recognise the needs of people with Pike, deputy director of campaigns, said: "For people living with dementia CHC can be an absolute lifeline, but some people will end up living in situations where they may spend the last few years of caring for somebody trying to fight the system."We've had it described to us as 'wading through treacle' in order to try and get the outcome you want, rather than spending that time with the person you love."The Department of Health and Social Care said responsibility for decisions about CHC funding lay with Local Integrated Care Boards, but as part of its 10 Year Health Plan it would be moving more healthcare out of hospitals and into the community, to ensure patients could access the care they needed. 'Disappointment and distress' Meanwhile, a spokesperson for WYICB said: "We have a responsibility to ensure that continuing healthcare decisions are fair, transparent and based on assessed need in accordance with the National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care."Decisions are based on NHS continuing healthcare assessments that are carried out by trained professionals using a nationally defined process."Decisions are based on an individual's assessed needs, not their diagnosis or financial situation."These assessments often involve people who are frail or have multiple needs, with families and carers providing considerable support."We appreciate that continuing healthcare decisions can be significant for individuals and families, especially in complex and sensitive circumstances, with outcomes potentially causing some disappointment and distress."While we cannot comment on individual cases, we can confirm that we are reviewing the matters raised here in line with our policy and complaints process."
Telegraph
13 hours ago
- Telegraph
Baby FGM death in the Gambia ‘should shame us all'
A one month old child has died after being subjected to female genital mutilation (FGM), reigniting anger and concern about the practice across the region. The infant reportedly died from severe bleeding after undergoing FGM in the West African country of The Gambia. Nimco Ali, a former Home Office advisor on violence against women and the CEO of the Five Foundation, a grassroots organisation tackling FGM, said the baby's death 'should shame us all'. 'She deserved so much more from us, and from an international community that boasts of caring for women and girls,' she told The Telegraph. FGM involves the deliberate cutting or removal of external female genitalia in the name of preserving so-called 'purity' and 'virginity'. Two women have been arrested for their alleged involvement, local police said. 'This is violence, pure and simple' The death of such a young girl has sparked widespread outrage in the tiny West African country, which officially banned FGM in 2015. Women In Leadership and Liberation, an organisation which works to protect the rights of women and girls in The Gambia, said: 'Culture is no excuse, tradition is no shield, this is violence, pure and simple.' Despite the ban, The Gambia has some of the world's highest rates of FGM, with at least 73 per cent of women and girls undergoing the procedure, most of them before the age of six, according to the World Health Organization (WHO). Experts say there has been an increase in young infants being subjected to FGM as parents attempt to evade prosecution. Last year, a bill seeking to repeal The Gambia's 2015 FGM ban, introduced by MP Almameh Gibba and supported by some religious leaders, passed its second reading but was ultimately rejected in parliament after intense lobbying from human rights campaigners. Mr Gibba had argued the ban violated citizens' rights to 'practice their culture and religion' in the majority Muslim country. Ms Ali, who is herself a survivor of FGM, said the child's death indicates not enough has been done to enforce the ban, however. 'Just last year, we stood with women in The Gambia to defend the ban on FGM, yet pro-FGM groups, flush with money and organisation, are still winning,' she said. It comes as the UK government has significantly reduced foreign aid spending on programmes related to sexual and reproductive health and rights, including initiatives aimed at ending FGM, as part of a wider cut to the overseas aid budget. The allocation was reduced from 0.5 to 0.3 per cent of gross national income in February. Spending on education, gender, and equality programmes in developing countries has been hit hardest – down 42 per cent from £490 million in 2024/25 to £284 million in 2025/26. 'In 2025, we are still forced to beg for adequate funding for grassroots organisations fighting on the frontline,' said Ms Ali. 'Without serious global backing, more girls will die.'
Daily Mirror
14 hours ago
- Daily Mirror
New programme with Mounjaro maker to tackle obesity in pharmacies
Thousands of NHS patients could see their treatment changing as a 'cutting-edge' programme begins The Government and pharmaceutical giant Eli Lilly, the creator of weight loss drug Mounjaro, are teaming up to explore and trial innovative solutions to the UK's obesity crisis, inviting NHS organisations to put forward fresh proposals. Announced on 12 August, this new health innovation scheme is supported by a hefty investment of up to £50million from the government and an additional £35million in grant funding from Lilly. A cool £10million has been set aside specifically to back proposals in Scotland, Wales and Northern Ireland. NHS bodies will be able to apply for part of this funding by proposing inventive approaches to caring for those battling obesity, beyond the current weight management services. The programme will also seek out novel methods of delivering obesity care that can be accessed by patients from all walks of life such as through pharmacies or online. Currently, the NHS provides a variety of services to assist people in managing their obesity, including prescription weight loss medication like Mounjaro and the NHS Digital Weight Management Programme. This is a 12-week online course offering dietary and activity guidance to support people transitioning to a healthier lifestyle. Approximately 28% of UK adults are categorised as obese according to a Healthy Survey for England. Alarmingly, about one in three children leaving primary school are overweight or living with obesity, as per the National Child Measurement Programme. Science and Technology Secretary Peter Kyle said: "New ways of accessing support to tackle obesity, such as through pharmacies or with help from digital tools, could be transformational for people's quality of life, and for society. Allowing individuals to more easily manage their weight and freeing them from ill-health that holds them back in daily life while reducing the strain on our NHS." NHS England national medical director Dr Claire Fuller said: "Obesity is one of the biggest public health challenges we face and costs the NHS billions of pounds every year, so this collaboration between government and industry to drive new ways of supporting people with obesity could make a huge difference. "The NHS is already developing and rolling out a range of ways to help people to manage their weight and live healthier lives, with patients benefiting from wraparound care from local weight management teams and via online support services, but we are excited by the potential of this collaboration to accelerate efforts to tackle obesity as the NHS moves from treatment to prevention as part of the 10-Year Health Plan." In certain areas , patients might begin utilising these ground-breaking services as soon as summer 2026. Eligibility for the programmes will be determined by local healthcare professionals in accordance with national guidelines and NHS standards. This fresh initiative aims to make it simpler for people battling obesity to obtain comprehensive, wraparound support via various channels. This should enhance patient outcomes and experiences whilst also reducing strain on the NHS and GPs, the Government claims. This marks the most recent scheme ministers have unveiled to combat obesity. Earlier interventions include curbs on unhealthy food marketing designed to prevent obesity from developing in the first place. Health Secretary Wes Streeting said: "Obesity is now one of the leading causes of ill health, costing the NHS billions. Yet, we now have the science, technology and knowledge to help tackle the obesity epidemic, if we seize this opportunity. "This collaboration will help patients living with obesity in a matter of months – through testing better access to weight loss services and treatments. In the long-term it will inform how we can better tackle one of the biggest modern day health challenges and, through our Plan for Change, create an NHS that is fit for the future." Professor Rachel Batterham, Senior Vice President for International Medical Affairs at Lilly stated: "The launch of this programme marks an important milestone in advancing new models of care for obesity. At Lilly, we are deeply committed to addressing the complex health challenge of obesity, and we are pleased to collaborate with the UK government and NHS partners. Together, we aim to build an evidence base that could transform health outcomes for people living with obesity."
